CClinicalTrials.gg
CompletedNCT01994356Updated Nov 25, 2013

Physician Self Disclosure of IUC Use

An interventional study of Physician self-disclosure of personal IUC use and Usual contraceptive counseling in Contraception, sponsored by University of Michigan. Completed at 1 site in United States. Open to female participants aged 18 Years to 44 Years. Per ClinicalTrials.gov, last updated 2013-11-25.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

As many as one-third of female healthcare providers use intrauterine contraception (IUC), but only about 8 percent of US women overall do. This begs the question: Might physician self-disclosure of personal IUC use increase IUC use among patients? However, the positive or negative impact of physician self disclosure on IUC uptake or patient satisfaction is generally unknown. The purpose of this study was to evaluate if physician self-disclosure of personal IUC use increases patient use of IUC or impacts patients' satisfaction with their clinical encounter.

Read the detailed description

We performed a prospective randomized block design pilot trail of usual contraceptive counseling versus usual counseling plus physician self-disclosure of personal intrauterine contraceptive use.

02

Conditions studied

  • Contraception

Keywords

  • Contraceptive counseling
  • Physician self disclosure
  • Satisfaction
  • Intrauterine contraceptive use
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • reproductive age
  • currently sexually active
  • scheduled for benign gynecology visit, annual exam, or family planning visit

Exclusion criteria

Exclusion Criteria:

  • seeking pregnancy within 1 year
  • currently using IUC
  • prior sterilization procedure
  • currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
132 participants (actual)

Study arms

  • Active comparator
    Usual contraceptive counseling

    subjects received usual contraceptive counseling

    Behavioral: Usual contraceptive counseling

  • Experimental
    Physician self-disclosure of IUC use

    subjects received usual contraceptive counseling plus intervention which was Physician self-disclosure of personal IUC use during the counseling

    Behavioral: Physician self-disclosure of personal IUC use

Interventions

  • BehavioralPhysician self-disclosure of personal IUC use

    Physicians self-disclosed personal intrauterine contraceptive use to subjects in intervention arm of study during contraceptive counseling

  • BehavioralUsual contraceptive counseling

    all subjects recieved usual contraceptive counseling

    Also known as: contraceptive counseling

06

What researchers measure

Primary outcomes

  1. Intrauterine contraceptive use

    All subjects were surveyed to determine use of intrauterine contraceptive immediately after their clinical visit where contraceptive counseling was received and at 2 months after their clinical encounter to assess intrauterine contraceptive use.

    Time frame: immediately following clinical encounter and at 2 months

Secondary outcomes

  1. Satisfaction with clinical encounter

    All subjects were surveyed to determine their with satisfaction with their overall clinical encounter immediately following their clinical encounter at at 2 months. Satisfaction was measured using a 5 point scale.

    Time frame: immediately following clinical encounter and at 2 months

Other outcomes

  1. Satisfaction with contraceptive method

    All subjects were surveyed to determine satisfaction with their contraceptive method of choice immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

    Time frame: immediately following clinical enocunter and at 2 months

  2. Satisfaction with provider

    All subjects were surveyed to determine satisfaction with their provider immediately following their clinical encounter and at 2 months. Satisfaction was measured using a 5 point scale.

    Time frame: immediately following clinical encounter and at 2 months

07

Study locations

1 site
  • University of Michigan Medical Center
    Ann Arbor, Michigan 48109, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01994356
Lead sponsor
University of Michigan
Responsible party
Mya Zapata (Clinical Lecturer, University of Michigan) — Principal investigator
First posted
Nov 25, 2013
Start date
Jan 2011
Primary completion
Feb 2013
Completion
Feb 2013
Last update
Nov 25, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion